How is the medical technology of Chongqing Xinqiao Hospital? Please 3Q
At present, the hospital has 149 scientific and technological personnel with senior titles, 162 medical doctoral and master's degree holders, 71 doctoral and master's degree instructors, and 558 doctoral and master's degree holders; 1 young and middle-aged expert with outstanding contributions at the national level, 1 recipient of the first batch of scientific and technological "Bole Prize" for the whole army, 1 recipient of the first batch of scientific and technological silver star for the whole army, and 25 experts who enjoy special allowances from the state government, with a group of high-quality talents with innovative ability. There are 25 experts enjoying national government special allowances, and a group of first-class talents with high quality and innovation ability. There are more than 1130 beds, 37 clinical and medical departments; the hospital has national key disciplines, national clinical pharmacology base, the All-Army Respiratory Medicine Research Institute, the All-Army Tumor Center, Chongqing Human Disease Genetic Research Institute, the National Second Class Laboratory Animal Center; there are key disciplines of Chongqing Municipal Key Laboratory, Chongqing Municipal Key Laboratory, the All-Army Key Laboratory; there is a postdoctoral clinical mobile station, and 31 doctoral and master's degree points authorized. Disciplines. In recent years, the hospital has increased capital investment, the introduction and updating of equipment, but also led to the introduction of new medical technology, new projects, now has the international advanced level of large and medium-sized medical equipment of nearly 1,000 units, the total value of the equipment 2. 600 million yuan. Xinqiao Hospital has been known for many famous doctors, distinctive features, and strong comprehensive strength, the hospital gives full play to the use of these three advantages, based on its own technological advantages, to create conditions for the organization of multidisciplinary collaboration, to carry out a number of large organ diseases as a leader, to improve the level of comprehensive treatment of the main high-standard, high starting point, broad market, wide range of applications, the disciplines and the construction of hospitals to drive the role of the sustainability of the strong role of the radiation role of the wide With the high, difficult and new technologies, the connotation construction of the hospital has reached a new level. The discipline of respiratory disease is a national key discipline, and its overall level is in the leading position in the country. The All-Army Institute of Respiratory Medicine is a key open laboratory of the whole army, with an area of 2,050 square meters in the experimental building, and instruments and equipments worth more than 6 million yuan, such as capillary electrophoresis, chromosome analyzer, lung function meter, etc.; under the leadership of the State Council Degree Evaluating Committee and the director of the All-Army Respiratory Medicine Committee, Mr. QIAN Guisheng, the Institute of Respiratory Medicine has reached the international advanced level in the study of the mechanism of the systemic inflammation response, the pathogenesis of ARDS, and the clinical diagnosis. The research on the regulation mechanism of systemic inflammatory reaction, the pathogenesis and clinical diagnosis of ARDS has reached the international advanced level, which has significantly reduced the death rate of ARDS in war and trauma, and was awarded the second prize of the National Scientific and Technological Progress. The diagnosis and treatment of bronchial asthma, pulmonary heart disease and lung cancer are at the advanced level in China, and the Chongqing Human Disease Gene Research Institute was set up in 1999 to carry out the cloning of human disease-related genes focusing on lung cancer and asthma, which is the first seed sown by Xinqiao Hospital and Chongqing Municipality in the fertile soil of China's human genome project. The Department of Cardiovascular Medicine is a national key discipline, taking the lead in carrying out percutaneous intracavitary coronary angioplasty and intracoronary stent implantation in Southwest China, with the scale and difficulty of coronary interventional therapy ranking the advanced level of the same industry in the country; the intracardiac electrophysiological specimen and transcatheter radiofrequency ablation have been penetrated into the ablation of difficult ventricular tachycardia and atrial flutter; and the "button type" artery catheter closure and interventricular catheterization of coronary heart disease has been developed. Arterial catheter closure and atrial septal defect repair, cardioverter defibrillation pacemaker (ICD) implantation, is one of the few units in China to carry out this procedure, the current cardiac intervention exceeds 1,000 cases per year, and the cumulative total reaches 5,000 cases, which reaches the advanced level of general hospitals. Nephrology Center is one of the first four hospitals in China to carry out kidney transplantation, with a total of more than 1,500 kidney transplants, and the clinical research on kidney transplantation for high-risk patients has won the second prize of Chongqing Scientific and Technological Achievements. Under the collaboration of multi-disciplinary research, the center has carried out 4 cases of pancreas-duodenum-kidney joint transplantation and 1 case of simple pancreas transplantation, and the first patient with pancreas-kidney joint transplantation has been healthy and survived for nearly 1 year, which is the first one in the military and the third one in China, and the technical level is at the advanced level in the world. At present, the center keeps the record of performing 20 kidney transplants a day by its own strength, and can start 30 times of hemodialysis every day at the same time, and the total number of dialysis treatments reaches 250,000 times. Cardiovascular Surgery is one of the potential disciplines in the hospital, and the whole department is young and enterprising, with an average age of 28.6 years old, and Prof. Shou Yingbin, who has been serving as the head of the department for four years, is only 37 years old; in 1997, the department carried out the operation of non-stop intracardiac visualization with shallow cryogenic extracorporeal circulation, which effectively improved the protection of myocardium during the operation, and increased the cases of operation, and the number of patients admitted has also increased from the original three provinces of Yunlin, Guiandao and Chuan to 12 provinces and autonomous regions of the country. The number of patients treated has also increased from the original three provinces of Yunnan, Guizhou and Sichuan to the current 12 provinces and autonomous regions in China. The three techniques of non-stop beating and small incision surgery for infants and young children with congenital heart disease, which were firstly carried out in China, take the lead in terms of level, quantity and the range of diseases treated in the country. The success of neonatal aorta complete transposition of three days of birth, congenital huge diaphragmatic hernia repair with left total lung atrophy in 12 hours of birth, and joint neonatal separation marks that our neonatal medical and surgical treatment, anesthesia, and nursing care technology have reached the national advanced level. The Department of Orthopaedic Surgery features spine surgery and bone and joint surgery, and is the first in China to carry out anterior cervical spine memory alloy expansion nail internal fixation, anterior cervical spine fusion with preservation of endplates, treating more than 500 cases of cervical spondylosis and cervical trauma, effectively solving the difficult problems of spinal cord decompression and cervical spine fusion, which is at a leading level in China. The Memory Expansion Nail was awarded the National Invention Patent and the Gold Medal of the 12th National Invention Achievement Expo. More than 10,000 cases of hip trauma, post-polio syndrome and congenital hip dislocation of old age have been treated, and the basic and clinical research on hip surgical treatment has won the second prize of the Army Medical Achievements. It has carried out new technologies such as imported artificial total hip joint replacement, total knee joint replacement, anterior KANADA, posterior Hastelloy bar, internal fixation with pedicle screws, etc., which has effectively improved the level of clinical treatment. The Army Cancer Specialized Center has more than 20 sets of large-scale equipments, such as linear gas pedal, simulation positioning machine, remote control rear-loaded internal irradiation therapy instrument, microwave cancer treatment instrument, etc., valued at RMB 30 million yuan, which form a comprehensive therapy branch with radiotherapy, chemotherapy, thermotherapy, electrochemotherapy and laser therapy, and carry out comprehensive treatment for tumor patients. It has treated more than 50 kinds of malignant tumors and more than 20,000 cases of tumor patients, and its high dose rate of intertissue and intracavitary implantation radiation therapy ranks the leading level in the country. It has made breakthroughs in intracavitary radiotherapy for lung cancer and lung atelectasis, guided therapy for lung cancer, limb-preserving therapy for malignant bone tumors, and breast-preserving therapy for the comprehensive treatment of early and middle-stage breast cancer, improving the survival rate and quality of life of patients. We have reached a consortium with the Institute of Radiation, Burn and Compound Injury of the university and the Department of Hematology, which has formed a pattern of mutual promotion between basic research and clinic, and the diagnosis and treatment of solid tumors and non-solid tumors, and the comprehensive strength of the Oncology Center is on the way to a new level. The Department of Neurosurgery takes the lead in the treatment of Parkinson's disease with brain tissue transplantation in China, and its basic research is in line with the international standard. It has carried out X-knife treatment for more than 300 cases of neurofunctional diseases and intracranial tumors, which is leading in China in terms of the types and number of diseases; it has formed a specialized treatment center featuring cerebral hemangiopathy, epilepsy surgery, stereotactic neurosurgery, and craniofacial tumors. Jointly with Oral and Maxillofacial Surgery to remove maxillofacial tumors invading into the middle skull base, and with Otorhinolaryngology and Ophthalmology to remove huge Ewing's tumors in the nasopharynx that widely invade into the nasal cavity, sinuses, orbits, skull base and frontal lobe, which marks a new breakthrough in the surgery of the skull base. Neurology neurophysiology research and treatment ranks the leading level in China, and cerebral ischemia treatment and research ranks the advanced level in China. The Physiotherapy Department has supplemented various treatment means to treat neck, shoulder, lumbar and leg pains, with an effective rate of 91%, and developed the third-generation infrared thermography diagnostic instrument, whose research on the basic and clinical application of medical infrared thermography has won 2 million yuan of funding from the National Planning Commission for research and development. The Emergency Department is equipped with more than 1 million yuan of rescue and monitoring instruments, and has opened the "Emergency Green Channel" to ensure that emergency patients are dealt with in a timely and effective manner, and to implement the integration of rescue-surgery-monitoring, which has successfully treated a large number of patients. The integration of rescue-surgery-monitoring has successfully treated a large number of patients with emergency treatment, and the rate of rescue and extrication is over 90%, which is at an advanced level in Southwest China; its emergency medical detachment can be assembled within 2 minutes upon receiving the call for help, and it can make rapid strikes and highly efficient treatments. Autologous bone marrow transplantation, right atrial inferior vena cava bypass for Buchanan's syndrome, multiplane transesophageal ultrasound, appendix out of the controlled cecum instead of bladder surgery, lung cancer, liver cancer guided treatment and other series of new technologies to carry out and accumulate, has greatly enhanced the ability of Xinqiao Hospital's large-organ comprehensive treatment. All in all, Xinqiao Hospital for the southwest region is no words.